NVCT

Analyst Sentiment

Wall St. Consensus
Buy
2 analysts·Low coverage
75
Score
2 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
2100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$10.00
-9.4%
Consensus
$10.00
-9.4%
Bull
$10.00
-9.4%
12-Month Target Range2 analysts
$10.00$10.00$10.00
Current $11.04Consensus
Current Price
$11.04
Above Consensus
$1.04

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+779.60%
EPS
FY2028
Rev+18.20%
EPS
FY2029
Rev+261.36%
EPS

Earnings Surprises

Recent Analyst Actions

Aug 4, 2025H.C. Wainwright
Nuvectis Pharma price target lowered to $10 from $15 at H.C. Wainwright
Target:$10.00
+37.2%from $7.29